CVS Health Corporation (NYSE:CVS)

Lester Mason
November 28, 2017

British Columbia Investment Management Corp lifted its stake in shares of CVS Health by 3.7% in the 1st quarter. The King Luther Capital Management Corp holds 373,376 shares with $30.04M value, down from 625,771 last quarter. St James Investment Company Llc who had been investing in Cvs Health Corp for a number of months, seems to be bullish on the $71.47B market cap company.

Shares of CVS Health Corp (NYSE:CVS) traded up $0.12 during trading on Monday, hitting $70.67. Trading was heavy with 2,992,871 shares changing hands by the end of trading on Friday.

CVS Health (NYSE:CVS) last issued its earnings results on Monday, November 6th. It has underperformed by 41.10% the S&P500. Utah Retirement invested in 186,700 shares. First City Capital Management Inc. lifted its position in CVS Health by 0.3% in the first quarter. Royce Value Tr Inc now has $1.32B valuation.

The stock decreased 6.07% or $0.025 on November 24, reaching $0.385. Bon-Ton Stores Inc (BONT) has declined 58.54% since November 27, 2016 and is downtrending. It has underperformed by 28.17% the S&P500.

Analysts await Netlist, Inc. Therefore 33% are positive. Superconductor had 4 analyst reports since September 25, 2015 according to SRatingsIntel. The stock of CVS Health Corp (NYSE:CVS) earned "Neutral" rating by Citigroup on Friday, November 3. The firm has "Neutral" rating given on Monday, October 23 by Citigroup. Robert W. Baird reissued a "hold" rating and set a $77.00 target price on shares of CVS Health in a research note on Friday, October 27th. The rating was maintained by Cantor Fitzgerald on Thursday, October 13 with "Buy". Leerink Swann maintained the shares of CVS in report on Tuesday, November 7 with "Outperform" rating. The company was maintained on Friday, June 9 by Jefferies.

Bon Ton Stores Inc (BONT) investors sentiment increased to 0.79 in Q2 2017. For the most recent quarter, quick ratio was 0.60, current ratio was 1.00, LT Debt/Equity ratio was 0.67 and Total Debt/Equity ratio stands at 0.74, while Payout ratio is 39.60%. It fall, as 81 investors sold BIIB shares while 321 reduced holdings. 180.66 million shares or 1.01% less from 182.50 million shares in 2017Q1 were reported. Given that liquidity is king in short-term, AMGN is a stock with 729.2 million shares outstanding that normally trades 1.09% of its float. 1832 Asset Management Lp reported 137,000 shares stake. (NASDAQ:NLST) to report earnings on April, 4. Palisade Asset Limited Liability Company owns 5,697 shares for 0.09% of their portfolio. Biltmore Wealth Ltd Liability Co accumulated 4,887 shares. Bartlett And Limited Company holds 468,889 shares. Hsbc Plc accumulated 302,924 shares. Zevin Asset Mgmt Lc stated it has 17,500 shares or 0.36% of all its holdings. Girard Prtn Limited accumulated 64,915 shares. The Maryland-based Financial Advantage Inc. has invested 0.02% in the stock. Beech Hill reported 0.17% in Biogen Inc (NASDAQ:BIIB). 7,436 are owned by Pinnacle Advisory Group Inc Inc. Southwest Airls Co Com (NYSE:LUV) was reduced too. When investing in a volatile security, the risk of success is increased just as much as the risk of failure. Its down 0.17, from 1.09 in 2017Q1. Farmers Merchants Invests invested in 0% or 3,280 shares. 108 funds opened positions while 483 raised stakes. CVS Health has $132 highest and $73 lowest target. Mechanics Commercial Bank Tru Department stated it has 53,809 shares or 1.03% of all its holdings. CVS's SI was 24.84M shares in November as released by FINRA. Cim Mangement reported 15,840 shares stake. Edgar Lomax Va stated it has 724,245 shares. Boston Partners reported 6.46 million shares stake. Richard C Young & Company Ltd holds 86,543 shares or 1.36% of its portfolio. 67,449 are held by Auxier Asset. Joel Isaacson & Ltd Liability has 0.68% invested in CVS Health Corp (NYSE:CVS) for 44,425 shares. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and fourteen have assigned a buy rating to the company's stock. Therefore 63% are positive. Finally, Wolfe Research downgraded CVS Health from an "outperform" rating to a "market perform" rating and cut their price target for the stock from $89.00 to $82.00 in a report on Monday, August 14th. The company was maintained on Wednesday, July 22 by Deutsche Bank. The stock has "Neutral" rating by Goldman Sachs on Thursday, December 17. SunTrust maintained CVS Health Corp (NYSE:CVS) rating on Friday, October 13. The consensus recommendation rating is a Moderate Buy.

A number of other brokerages also recently commented on CVS. Jefferies maintained the shares of CVS in report on Friday, June 9 with "Hold" rating. The stock of CVS Health Corp (NYSE:CVS) earned "Buy" rating by Oppenheimer on Tuesday, August 8. Cap Rech Global reported 3.51 million shares.

Since June 12, 2017, it had 0 insider buys, and 1 insider sale for $18.44 million activity. Also, insider Larry J. Merlo sold 241,150 shares of the company's stock in a transaction that occurred on Wednesday, September 13th.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by Iphone Fresh

Discuss This Article